Presentation is loading. Please wait.

Presentation is loading. Please wait.

Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study  Jeremy Waldram, MD, Kristen Walters,

Similar presentations


Presentation on theme: "Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study  Jeremy Waldram, MD, Kristen Walters,"— Presentation transcript:

1 Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study  Jeremy Waldram, MD, Kristen Walters, MD, Ronald Simon, MD, Katherine Woessner, MD, Jill Waalen, MD, MPH, Andrew White, MD  Journal of Allergy and Clinical Immunology  Volume 141, Issue 1, Pages (January 2018) DOI: /j.jaci Copyright © Terms and Conditions

2 Fig 1 Nasal ketorolac and oral aspirin challenge protocol. After reactions are treated and resolve, continue the next scheduled ketorolac dose or repeat the oral provoking aspirin dose. Desensitization is complete after 325 mg of aspirin. The patient should take 650 mg of aspirin that evening and then continue 650 mg twice daily as their continuous aspirin dose until further instructed. If no reaction occurs within 3 hours after a 325-mg dose, consider it a negative challenge result. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © Terms and Conditions


Download ppt "Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study  Jeremy Waldram, MD, Kristen Walters,"

Similar presentations


Ads by Google